ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

Two Breast Cancer Screening Methods Found Equivalent

August 29, 2008

In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte

March 8, 1991

Former BMS Executive Bodnar Indicted.

April 25, 2008

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007